Recombinant human growth hormone and oxandrolone in treatment of short stature in girls with Turner syndrome.

Three-year results of treatment with growth hormone, alone or associated with oxandrolone, in girls with Turner syndrome. The Kabi Collaborative Study Group.

Growth curves for girls with Turner syndrome.

Comparison of growth hormone treatment in patients with idiopathic short stature and idiopathic growth hormone deficiency.

Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome.

Oxandrolone therapy for children with Turner syndrome.

Oxandrolone increases final height in Turner syndrome.

Effect of growth hormone treatment on children with idiopathic short stature and idiopathic growth hormone deficiency.

Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes.

Efficacy of short-term growth hormone treatment in prepubertal children with idiopathic short stature.

Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group.

Short Stature in KBG Syndrome: First Responses to Growth Hormone Treatment.

Growth curves for Turkish Girls with Turner Syndrome: Results of the Turkish Turner Syndrome Study Group.

Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome.

Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone.

Preservation of physiological growth hormone (GH) secretion in idiopathic short stature after recombinant GH therapy.

Constitutional delay influences the auxological response to growth hormone treatment in children with short stature and growth hormone sufficiency.

The effect of growth hormone treatment on height in children with idiopathic short stature.

The effect of short-term growth hormone or low-dose oxandrolone treatment in boys with constitutional growth delay.

Growth hormone secretory status in patients with Turner syndrome.

Effects of recombinant human growth hormone therapy on carbohydrate, lipid and protein metabolisms of children with Turner syndrome.

Treatment of constitutional delay of growth and puberty with oxandrolone compared with growth hormone.

Turner syndrome in Albania and the efficacy of its treatment with growth hormone.

Effect of androgen on growth hormone secretion and growth in boys with short stature.

Severe short stature and Wolf-Hirschhorn syndrome: response to growth hormone in two cases without growth hormone deficiency.

Suggest Documents

Three-year results of treatment with growth hormone, alone or associated with oxandrolone, in girls with Turner syndrome. The Kabi Collaborative Study Group.

Growth curves for girls with Turner syndrome.

Comparison of growth hormone treatment in patients with idiopathic short stature and idiopathic growth hormone deficiency.

Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome.

Oxandrolone therapy for children with Turner syndrome.

Oxandrolone increases final height in Turner syndrome.

Effect of growth hormone treatment on children with idiopathic short stature and idiopathic growth hormone deficiency.

Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes.

Efficacy of short-term growth hormone treatment in prepubertal children with idiopathic short stature.

Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group.

Short Stature in KBG Syndrome: First Responses to Growth Hormone Treatment.

Growth curves for Turkish Girls with Turner Syndrome: Results of the Turkish Turner Syndrome Study Group.

Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome.

Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone.

Preservation of physiological growth hormone (GH) secretion in idiopathic short stature after recombinant GH therapy.

Constitutional delay influences the auxological response to growth hormone treatment in children with short stature and growth hormone sufficiency.

The effect of growth hormone treatment on height in children with idiopathic short stature.

The effect of short-term growth hormone or low-dose oxandrolone treatment in boys with constitutional growth delay.

Growth hormone secretory status in patients with Turner syndrome.

Effects of recombinant human growth hormone therapy on carbohydrate, lipid and protein metabolisms of children with Turner syndrome.

Treatment of constitutional delay of growth and puberty with oxandrolone compared with growth hormone.

Turner syndrome in Albania and the efficacy of its treatment with growth hormone.

Effect of androgen on growth hormone secretion and growth in boys with short stature.

Severe short stature and Wolf-Hirschhorn syndrome: response to growth hormone in two cases without growth hormone deficiency.

Recombinant human growth hormone and oxandrolone in treatment of short stature in girls with Turner syndrome.

Recommend Documents

Follow Us